BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26026721)

  • 21. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
    Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive functions in multiple sclerosis: impact of gray matter integrity.
    Llufriu S; Martinez-Heras E; Fortea J; Blanco Y; Berenguer J; Gabilondo I; Ibarretxe-Bilbao N; Falcon C; Sepulveda M; Sola-Valls N; Bargallo N; Graus F; Villoslada P; Saiz A
    Mult Scler; 2014 Apr; 20(4):424-32. PubMed ID: 24005025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
    Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
    J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrity of hypothalamic fibers and cognitive fatigue in multiple sclerosis.
    Hanken K; Eling P; Kastrup A; Klein J; Hildebrandt H
    Mult Scler Relat Disord; 2015 Jan; 4(1):39-46. PubMed ID: 25787051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple white matter tract abnormalities underlie cognitive impairment in RRMS.
    Yu HJ; Christodoulou C; Bhise V; Greenblatt D; Patel Y; Serafin D; Maletic-Savatic M; Krupp LB; Wagshul ME
    Neuroimage; 2012 Feb; 59(4):3713-22. PubMed ID: 22062194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal cervical cord function contributes to fatigue in multiple sclerosis.
    Rocca MA; Absinta M; Valsasina P; Copetti M; Caputo D; Comi G; Filippi M
    Mult Scler; 2012 Nov; 18(11):1552-9. PubMed ID: 22389415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion tensor imaging findings in the multiple sclerosis patients and their relationships to various aspects of disability.
    Pokryszko-Dragan A; Banaszek A; Nowakowska-Kotas M; Jeżowska-Jurczyk K; Dziadkowiak E; Gruszka E; Zagrajek M; Bilińska M; Budrewicz S; Sąsiadek M; Bladowska J
    J Neurol Sci; 2018 Aug; 391():127-133. PubMed ID: 30103962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.
    Simioni S; Amarù F; Bonnier G; Kober T; Rotzinger D; Du Pasquier R; Schluep M; Meuli R; Sbarbati A; Thiran JP; Krueger G; Granziera C
    J Neurol; 2014 Aug; 261(8):1606-13. PubMed ID: 24912471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging.
    Li HQ; Yin B; Quan C; Geng DY; Yu H; Bao YF; Liu J; Li YX
    BMC Neurol; 2018 Aug; 18(1):108. PubMed ID: 30086721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transverse diffusivity of cerebral parenchyma predicts visual tracking performance in relapsing-remitting multiple sclerosis.
    Warlop NP; Achten E; Fieremans E; Debruyne J; Vingerhoets G
    Brain Cogn; 2009 Dec; 71(3):410-5. PubMed ID: 19576672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis.
    Zhou F; Zhuang Y; Gong H; Zhan J; Grossman M; Wang Z
    PLoS One; 2016; 11(1):e0146080. PubMed ID: 26727514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
    Hayter AL; Salkovskis PM; Silber E; Morris RG
    Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.
    Deppe M; Krämer J; Tenberge JG; Marinell J; Schwindt W; Deppe K; Groppa S; Wiendl H; Meuth SG
    Hum Brain Mapp; 2016 May; 37(5):1866-79. PubMed ID: 26920497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
    Papathanasiou A; Messinis L; Zampakis P; Panagiotakis G; Gourzis P; Georgiou V; Papathanasopoulos P
    J Neurol Sci; 2015 Nov; 358(1-2):236-42. PubMed ID: 26359854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
    Asaf A; Evan S; Anat A
    Neuroimage Clin; 2015; 8():261-6. PubMed ID: 26106550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disability as a determinant of fatigue in MS patients.
    Taveira FM; Braz NFT; Comini-Frota ER; Teixeira AL; Domingues RB
    Arq Neuropsiquiatr; 2019 May; 77(4):248-253. PubMed ID: 31090805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
    Caligiuri ME; Barone S; Cherubini A; Augimeri A; Chiriaco C; Trotta M; Granata A; Filippelli E; Perrotta P; Valentino P; Quattrone A
    Neuroimage Clin; 2015; 7():28-33. PubMed ID: 25610764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.